Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Radioiodine Therapy for Hyperthyroidism
source: The New England Journal of Medicine
year: 2011
authors: Douglas S. Ross
summary/abstract:A 37-year-old woman receives a diagnosis of Graves’ disease and is treated with methimazole for 1 year. After completing this treatment, she presents with recurrent symptoms of hyperthyroidism. Radioiodine ablation is recommended.
organization: Massachusetts General Hospital, USADOI: 10.1056/NEJMct1007101
read more full text
Related Content
-
Predictive Score for the Development or Progression of Graves’ Orbitopathy in Patients With Newly Diagnosed Gr...Objective: To construct a predictive sc...
-
Management of Graves’ Disease: A ReviewImportance: Graves disease is the most ...
-
Radioactive Iodine Treatment for HyperthyroidismThe thyroid gland, located at the front ...
-
A Prospective Study of the Effects of Radioiodine Therapy for Hyperthyroidism in Patients With Minimally Active Grav...Context: Radioiodine is an effective an...
-
Cancer Incidence and Mortality After Radioiodine Treatment for Hyperthyroidism: A Population-Based Cohort StudyBackground: Radioiodine is used increas...
-
Post-Partum and Non-Post-Partum Relapsing Graves’ Hyperthyroidism Display Different Response to Anti-Thyroid D...Design: Graves’ disease (GD) patients...
-
Effects of Selenium on Short-Term Control of Hyperthyroidism due to Graves’ Disease Treated With Methimazole: ...Objective: In spite of previous conflic...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
myBinder